The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Tabeeva G.R.

Moskovskaia meditsinskaia akademiia im. I.M. Sechenova

Mixed dementia: the role of cerebrovascular pathology

Authors:

Tabeeva G.R.

More about the authors

Read: 4658 times


To cite this article:

Tabeeva GR. Mixed dementia: the role of cerebrovascular pathology. S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(9):111‑116. (In Russ.)
https://doi.org/10.17116/jnevro2018118091111

Recommended articles:
Como­rbidity of depression and deme­ntia: epidemiological, biological and therapeutic aspe­cts. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):113-121
Non-invasive biomarkers for early diagnosis of Alzheimer’s disease in bodily fluids. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):8-16
Animal expe­rimental models in the study of age-dependent cere­bral microangiopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):57-68
Cyto­kine status of patients with Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):5-12
Differential diagnosis of Alzheimer’s disease and vascular cognitive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):26-35
A comprehensive study of Alzheimer’s disease biomarkers in plasma and cere­brospinal fluid. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):43-53

References:

  1. Wortmann M. Dementia: a global health priority-highlights from an ADI and World Health Organization report. Alzheimers Res Ther. 2012;4:40. https://doi.org/10.1186/alzrt143
  2. Loeb C. The history of vascular dementia. J Hist Neurosci. 1995;4:121-126. https://doi.org/10.1080/09647049509525631
  3. Hachinski VC, Lassen NA, Marshall J. Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet. 1974;2:207-210. https://doi.org/10.1016/S0140-6736(74)91496-2
  4. Schreiber S, Bueche CZ, Garz C, Braun H. Blood brain barrier breakdown as the starting point of cerebral small vessel disease? New insights from a rat model. Exp Transl Stroke Med. 2013;5:4. https://doi.org/10.1186/2040-7378-5-4
  5. Nelson PT, Head E, Schmitt FA, Davis PR, Neltner JH, Jicha GA, Abner EL, Smith CD, Van Eldik LJ, Kryscio RJ, Scheff SW. Alzheimer’s disease is not «brain aging»: neuropathological, genetic, and epidemiological human studies. Acta Neuropathol. 2011;121:571-587. https://doi.org/10.1007/s00401-011-0826-y
  6. Shim YS, Roe CM, Buckles VD, Morris JC. Clinicopathologic study of Alzheimer’s disease: Alzheimer mimics. J Alzheimers Dis. 2013;35:799-811. https://doi.org/10.3233/JAD-121594
  7. Tomlinson BE, Blessed G, Roth M. Observations on the brains of non-demented old people. J Neurol Sci. 1968;7:331-356.
  8. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease: The Nun Study. JAMA. 1997;277:813-817. https://doi.org/10.1001/jama.1997.03540340047031
  9. Chui HC, Ramirez-Gomez L. Clinical and imaging features of mixed Alzheimer and vascular pathologies. Alzheimers Res Ther. 2015;7(1):21. https://doi.org/10.1186/s13195-015-0104-7
  10. Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007;69:2197-2204. https://doi.org/10.1212/01.wnl.0000271090.28148.24
  11. Matsui Y, Tanizaki Y, Arima H, Yonemoto K, Doi Y, Ninomiya T, Sasaki K, Iida M, Iwaki T, Kanba S, Kiyohara Y. Incidence and survival of dementia in a general population of Japanese elderly: the Hisayama study. J Neurol Neurosurg Psychiatry. 2009;80:366-370. https://doi.org/10.1136/jnnp.2008.155481
  12. White L. Brain lesions at autopsy in older Japanese-American men as related to cognitive impairment and dementia in the final years of life: a summary report from the Honolulu-Asia aging study. J Alzheimers Dis. 2009;18:713-725. https://doi.org/10.3233/JAD-2009-1178
  13. Arvanitakis Z, Leurgans SE, Barnes LL, Bennett DA, Schneider JA. Microinfarct pathology, dementia, and cognitive systems. Stroke. 2011;42:722-727. https://doi.org/10.1161/STROKEAHA.110.595082
  14. Bhaskar K, Konerth M, Kokiko-Cochran ON, Cardona A, Ransohoff RM, Lamb BT. Regulation of tau pathology by the microglial fractalkine receptor. Neuron. 2010;68:19-31. https://doi.org/10.1016/j.neuron.2010.08.023
  15. Hunter JM, Kwan J, Malek-Ahmadi M, Maarouf CL, Kokjohn TA, Belden C, Sabbagh MN, Beach TG, Roher AE.. Morphological and pathological evolution of the brain microcirculation in aging and Alzheimer’s disease. PLoS One. 2012;7:36893. https://doi.org/10.1371/journal.pone.0036893
  16. Iadecola C. The pathobiology of vascular dementia. Neuron. 2013;80:844-866. https://doi.org/10.1016/j.neuron.2013.10.008
  17. Barker WW, Luis CA, Kashuba A, Luis M, Harwood DG, Loewenstein D, Waters C, Jimison P, Shepherd E, Sevush S, Graff-Radford N, Newland D, Todd M, Miller B, Gold M, Heilman K, Doty L, Goodman I, Robinson B, Pearl G, Dickson D, Duara R. Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord. 2002;16:203-212.
  18. Ghebremedhin E, Rosenberger A, Rub U, Vuksic M, Berhe T, Bickeboller H, de Vos RA, Thal DR, Deller T. Inverse relationship between cerebrovascular lesions and severity of lewy body pathology in patients with lewy body diseases. J Neuropathol Exp Neurol. 2010;69:442-448. https://doi.org/10.1097/NEN.0b013e3181d88e63
  19. Rabinovici GD, Miller BL. Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management. CNS Drugs. 2010;24:375-398. https://doi.org/10.2165/11533100-000000000-00000
  20. Pires PW, Dams Ramos CM, Matin N, Dorrance AM. The effects of hypertension on the cerebral circulation. Am J Physiol Heart Circ Physiol. 2013;304:1598-1614. https://doi.org/10.1152/ajpheart.00490.2012
  21. Shah NS, Vidal JS, Masaki K, Petrovitch H, Ross GW, Tilley C, Tilley C, DeMattos RB, Tracy RP, White LR, Launer LJ. Midlife blood pressure, plasma beta-amyloid, and the risk for Alzheimer disease: the Honolulu Asia Aging Study. Hypertension. 2012;59:780-786. https://doi.org/10.1161/HYPERTENSIONAHA.111.178962
  22. Meraz-Rios MA, Toral-Rios D, Franco-Bocanegra D, Villeda-Hernandez J, Campos-Pena V. Inflammatory process in Alzheimer’s Disease. Front Integr Neurosci. 2013;7:59. https://doi.org/10.3389/fnint.2013.00059
  23. Sagare AP, Bell RD, Zlokovic BV. Neurovascular dysfunction and faulty amyloid beta-peptide clearance in Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2:a011452. https://doi.org/10.1101/cshperspect.a011452
  24. Rosenberg GA. Neurological diseases in relation to the blood-brain barrier. J Cereb Blood Flow Metab. 2012;32:1139-1151. https://doi.org/10.1038/jcbfm.2011.197
  25. Bogolepova AN. A modern concept of mixed dementia. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2015;115(5):120-126. (In Russ.) https://doi.org/10.17116/jnevro201511551120-126
  26. Levin OS. Diagnosis and treatment of dementia in clinical practice. M.: MEDpress-Inform; 2009. (In Russ.)
  27. Daniel F, Shams S, Cavallin L, Viitanen M, Martola J, Granberg T, Shams M, Aspelin P, Kristoffersen-Wiberg M, Nordberg A, Wahlund LO, Westman E. The contribution of small vessel disease to subtypes of Alzheimer’s disease: a study on cerebrospinal fluid and imaging biomarkers. Neurobiology of Aging. 2018;70:18-29. https://doi.org/10.1016/j.neurobiolaging.2018.05.028
  28. Budni J, Bellettini-Santos T, Mina F, Garcez ML, Zugno AI. The involvement of BDNF, NGF and GDNF in aging and Alzheimer’s disease. Aging and Diseases. 2015;6(5):331-341. https://doi.org/10.14336/AD.2015.0825
  29. Chao MV, Rajagopal R, Lee FS. Neurotrophin signaling in health and disease. Clinical Science (London). 2006;110(2):167-173. https://doi.org/10.1042/CS20050163
  30. Masliah E, Iez-Tejedor E. The pharmacology of neurotrophic treatment with Cerebrolysin: Brain protectionand repair to counteract pathologies of acute and chronic neurological disorders. Drugs Today (Barcelona). 2012;48 (suppl. A):3-24. https://doi.org/10.1358/dot.2012.48(Suppl.A).1739716
  31. Ukraintseva SV, Arbeev KG, Michalsky AI, Yashin AI. Antiaging treatments have been legally prescribed for approximately thirty years. Annals of the New York Academy of Science. 2004;1019:64-69. https://doi.org/10.1196/annals.1297.014
  32. Stepanichev M, Onufriev M, Aniol V, Freiman S, Brandstaetter H, Winter S, Lazareva N, Guekht A, Gulyaeva N. Effects of cerebrolysin on nerve growth factor system in the aging rat brain. Restorative Neurology and Neuroscience. 2017;35:571-581. https://doi.org/10.3233/RNN-170724
  33. Chen N, Yang M, Guo J, Zhou M, Zhu C, He L. Cerebrolysin for vascular dementia. Cochrane Database of Systematic Reviews. 2013;1:CD008900. https://doi.org/10.1002/14651858.CD008900.pub2
  34. Gauthier S, Proaño JV, Jia J, Froelich L, Vester JC, Doppler E. Cerebrolysin in Mild-to-Moderate Alzheimer’s Disease: A Meta-Analysis of Randomized Controlled Clinical Trials. Dement Geriatr Cogn Disord. 2015;39:332-347. https://doi.org/10.1159/000377672

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.